iShares Trust - iShares Biotechnology ETF Dividends and Buybacks

Dividend criteria checks 0/6

iShares Trust - iShares Biotechnology ETF is a dividend paying company with a current yield of 0.3%.

Key information

0.3%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yield	n/a
Future Dividend Yield	n/a
Dividend Growth	n/a
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	US$0.410
Payout ratio	5%

Recent dividend and buyback updates

No updates

Recent updates

iShares Biotechnology ETF: Playing Defense

Dec 10

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Oct 14

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Jul 28

IBB: Lows After Highs Highlight Failing Growth Narratives And Overvaluation In Biotech Sector

May 09

IBB: Healthcare Dashboard For April

Apr 18

XBI And IBB: You May Keep Laughing While We Keep Buying This March 2020-Like Opportunity

Jan 28

Biotech Investing: Large Trading Volumes Suggest Better Days Are Ahead

Jan 17

IBB And XBI: 4 Reasons To Buy Biotech Stocks Ahead Of 2022

Dec 06

IBB: Healthcare Dashboard For October

Oct 15

IBB: Risks And Hedging

Sep 21

IBB: Growth And Innovation

Jun 28

AbbVie rated buy at Mizuho despite patent cliff for Humira

Jan 11

NASDAQ Biotech Index cross 5,000-mark as vaccine makers and gene-editors surge

Jan 08

iShares Nasdaq Biotechnology ETF: Continuous Innovation For Mankind

Jan 06

Citing uncertainty, Baird stays neutral on Biotech for 2021

Jan 04

COVID-19 vaccine makers: Looking back on 2020 seeking insights for 2021

Dec 31

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: IBB is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: IBB is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.

Dividend Yield vs Market

iShares Trust - iShares Biotechnology ETF Dividend Yield vs Market

How does IBB dividend yield compare to the market?
Segment	Dividend Yield
Company (IBB)	0.3%
Market Bottom 25% (US)	1.4%
Market Top 25% (US)	4.5%
Industry Average (Capital Markets)	1.9%
Analyst forecast (IBB) (up to 3 years)	n/a

Notable Dividend: IBB's dividend (0.3%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.42%).

High Dividend: IBB's dividend (0.3%) is low compared to the top 25% of dividend payers in the US market (4.46%).

Earnings Payout to Shareholders

Earnings Coverage: IBB is not paying a notable dividend for the US market.

Cash Payout to Shareholders

Cash Flow Coverage: Insufficient data to calculate IBB's cash payout ratio to determine if its dividend payments are covered by cash flows.

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/07 17:32
End of Day Share Price	2025/02/07 00:00
Earnings	2023/09/30
Annual Earnings	2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

iShares Trust - iShares Biotechnology ETF is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.